Home > Resources > Whitepapers > The Role of Patient-Reported Outcome Clinical Trials & Treatment

The Role of Patient-Reported Outcome Clinical Trials & Treatment

October 6, 2016

Pharm Exec convened a roundtable discussion, moderated by Editorial Director William Looney, during the 2016 American Society of Clinical Oncology Annual Meeting, to examine a central question in cancer treatment today: in the evaluation of benefit to patients and society of a novel therapy, what should be the role/contribution of patientreported outcome (PRO) measures that incorporate insights from the real-life patient experience? PRO received close attention at ASCO, just as it is getting close attention from the Food and Drug Administration, the European Medicines Agency and other global regulators, as well as from industry, payers and patient advocates.

Spotlight

Jaga-Me

Jaga-Me is an on-demand platform for the elderly and discharging patients to obtain home nursing and caregiving services. Our mission is bring quality healthcare to homes, and empower communities to care. We do so by connecting them with care professionals in the same community, and providing them with the necessary tools and support to provide quality healthcare at home.

OTHER WHITEPAPERS

Value Based Procurement in MedTech

whitePaper | February 3, 2022

Value Based Procurement (VBP) is a method in which procurement decisions are made focused on total value rather than cost.

IQVIA Hospital Information System

whitePaper | November 5, 2022

IQVIA enabled the successful adoption of a new HIS in Ministry of Health hospitals across three regions in Kingdom of Saudi Arabia with innovative change management models.

Healthcare At The Edge

whitePaper | April 6, 2021

Delivering quality care to patients requires much more than just good intentions. Healthcare providers must respond to constantly evolving technological, financial and security challenges with digital infrastructure that can meet their needs. Learn about a platform solution built to succeed in the modern healthcare landscape.

2023 Healthcare Trends in Emerging Markets: A Look Ahead

whitePaper | January 14, 2023

After being hit the hardest by the pandemic, many emerging market stakeholders are now looking for impactful, long-term partnerships with global healthcare companies that add real value to local populations.

As patient care channels become more fragmented, communications & coordination can become integrated

whitePaper | June 30, 2022

A platform approach to clinical communications keeps clinicians connected and patient data more secure

Maximize the Benefits of Your CI/CD Pipeline by Including theMainframe

whitePaper | September 23, 2022

The events of recent years, prior to and including the pandemic, have revealed just how greatly the world needs vastly increased amounts of reliable computing power for healthcare organizations to satisfy the total member/patient experience for things like telehealth.

The Role of Patient-Reported Outcome Clinical Trials & Treatment